Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Bruce A. Chabner, M.D.


This page shows the publications co-authored by Bruce Chabner and Jeffrey Clark.
Connection Strength

  1. Clark JW, Chabner BA. Limits to Precision Cancer Medicine. N Engl J Med. 2017 01 05; 376(1):96.
    View in: PubMed
    Score: 0.764
  2. Izar B, Rotow J, Gainor J, Clark J, Chabner B. Pharmacokinetics, clinical indications, and resistance mechanisms in molecular targeted therapies in cancer. Pharmacol Rev. 2013; 65(4):1351-95.
    View in: PubMed
    Score: 0.152
  3. Goulart BH, Clark JW, Pien HH, Roberts TG, Finkelstein SN, Chabner BA. Trends in the use and role of biomarkers in phase I oncology trials. Clin Cancer Res. 2007 Nov 15; 13(22 Pt 1):6719-26.
    View in: PubMed
    Score: 0.101
  4. Kwak EL, Clark JW, Chabner B. Targeted agents: the rules of combination. Clin Cancer Res. 2007 Sep 15; 13(18 Pt 1):5232-7.
    View in: PubMed
    Score: 0.100
  5. Roberts TG, Goulart BH, Squitieri L, Stallings SC, Halpern EF, Chabner BA, Gazelle GS, Finkelstein SN, Clark JW. Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials. JAMA. 2004 Nov 03; 292(17):2130-40.
    View in: PubMed
    Score: 0.082
  6. Brugarolas J, Clark JW, Chabner B. Using "rationally designed drugs" rationally. Lancet. 2003 May 24; 361(9371):1758-9.
    View in: PubMed
    Score: 0.074
  7. Zhu AX, Puchalski TA, Stanton VP, Ryan DP, Clark JW, Nesbitt S, Charlat O, Kelly P, Kreconus E, Chabner BA, Supko JG. Dihydropyrimidine dehydrogenase and thymidylate synthase polymorphisms and their association with 5-fluorouracil/leucovorin chemotherapy in colorectal cancer. Clin Colorectal Cancer. 2004 Feb; 3(4):225-34.
    View in: PubMed
    Score: 0.019
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.